Ad
related to: intranasal
Search results
Predictive Oncology Inc (POAI) (Q1 2024) Earnings Call Transcrip
Guru Focus· 3 days agoCash and Cash Equivalents: $5.2 million as of Q1 2024, down from $8.7 million as of end of 2023.Stockholders' Equity: $4.0 million as of Q1 2024, down from $8.
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoWe also announced recently that we are making meaningful progress with FluGen in the development of a first-of-its-kind intranasal flu vaccine. This project is part of a $6.2 ...
Q1 2024 NRX Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoWe anticipate that this will be the commercial product we bring to market to support HOPE Therapeutics. While IV ketamine offers numerous benefits to patients, it's cumbersome for administration ...
Tiziana eyes orphan drug designation for multiple sclerosis treatment
Proactive Investors· 5 days agoTiziana’s intranasal foralumab would be the first to receive the designation for non-active...
Summer Safety for Mom & Baby
KAMR Amarillo· 4 days agoAMARILLO, Texas (KAMR/KCIT) —Summer time is almost here, and that means the new and expecting moms might have questions when it comes to things like...
Revelation Biosciences, Inc. (NASDAQ:REVB) to Post Q2 2024 Earnings of ($1.34) Per Share, Roth...
ETF DAILY NEWS· 3 days agoRevelation Biosciences, Inc. (NASDAQ:REVB – Free Report) – Investment analysts at Roth Capital raised their Q2 2024 earnings per share (EPS) estimates for shares of Revelation Biosciences in ...
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business...
Rome Sentinel· 4 days agoPositive data from a Phase 2b/3 trial of NRX-101 in Treatment Resistant Bipolar Depression (TRBD); trial demonstrated depression efficacy comparable to standard of care and significant reduction ...
Page A16
The Wahpeton Daily News· 4 days agoThe Richland County Board of Commissioners met Tuesday, May 7. John Anderson gave a buildings and grounds update on the courthouse project. Commissioner...
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded to “Buy” by StockNews.com
ETF DAILY NEWS· 4 days agoJPMorgan Chase & Co. initiated coverage on Amphastar Pharmaceuticals in a research note on Tuesday, March 5th. Needham & Company LLC reaffirmed a hold rating on shares of Amphastar Pharmaceuticals ...
Enhanced potency of an IgM-like nanobody targeting conserved epitope in SARS-CoV-2 spike N-terminal...
Nature· 5 days agoCompared to N235, MN235 exhibits varied enhancement in neutralization against pseudotyped and authentic viruses in vitro. The intranasal administration of MN235 in low doses ...
